FDA Drug Application (091662) for HYDROCHLOROTHIAZIDE by LANNETT HOLDINGS INC

Back to FDA Applications sponsored by LANNETT HOLDINGS INC

Application Number091662
Product Number001
FormCAPSULE;ORAL
Dosage12.5MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameHYDROCHLOROTHIAZIDE
Active IngredientHYDROCHLOROTHIAZIDE



Back to FDA Applications sponsored by LANNETT HOLDINGS INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.